Executive Q&A - Empowering Diagnostic Clarity in Hematologic Malignancies

Each year, NGS testing becomes increasingly important for identifying subtypes and treatment options in hematologic malignancies.

In this Executive Q&A video, medical director of Labcorp's Brentwood, Tennessee Stephanie McAlhany, discusses the lab's hematology testing, and about the support they offer in choosing tests and interpreting results.